Influence
January 10, 2025

Asthma Among Children With Primary Ciliary Dyskinesia

Arthur H. Owora, PhD

Published in the journal JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Arthur H. Owora, PhD, MPH

This case-control study investigated whether asthma should be routinely considered a comorbidity in children with primary ciliary dyskinesia (PCD), a condition caused by mutations in genes affecting motile cilia. Researchers analyzed data from two large electronic health record databases—Indiana Network for Patient Care Research (INPCR) and TriNetX—focusing on children 18 years or younger with both bronchiectasis and situs inversus totalis (B-SIT), a combination highly indicative of PCD. In INPCR, all 9 children with B-SIT had asthma, compared to 1 of 27 controls (P < .001). In TriNetX, 84 of 115 children with B-SIT had asthma, compared to 12 of 115 controls (P = 2.2 × 10⁻¹⁶), with an adjusted odds ratio of 22.3. The study concludes that asthma is significantly more common in children with likely PCD. This supports prior research suggesting antigen stasis in PCD may contribute to asthma-like inflammation. The findings suggest children with PCD should be evaluated for asthma, and some children with asthma may warrant evaluation for underlying PCD features.

Author Affiliations

Joe Zein 1, Arthur Owora 2 3, Hyun Jo Kim 4, Nadzeya Marozkina 2, Benjamin Gaston 2
Affiliations

Affiliations

1Department of Medicine, Division of Pulmonary and Sleep Medicine, Mayo Clinic, Scottsdale, Arizona.

2Department of Pediatrics and Riley Hospital for Children, Indiana University School of Medicine, Indianapolis.

3Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana.

4Department of Bioinformatics and Systems Biology, Case Western Reserve University, Cleveland, Ohio.

Related News

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher

Rachel Patzer, PhD, MPH

Building trust in healthcare AI through data and evidence

As artificial intelligence rapidly transforms healthcare, innovation alone is not enough. Health systems need evidence that AI tools are

doctor using electronic health record

Data expertise helps researchers understand how clinical tools are used in real-world care

Regenstrief Data Services (RDS) provided critical health data and specialized expertise to support research examining clinical decision-support use across

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a